Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Almost all pharmaceuticals are driven by the cost of drug discovery and studies. You want the cost of drugs to be enough to drive investment into new drugs, but not so much that it becomes impractical for people to afford.
So, what exactly about this drug is hard to manufacture? Is it solely the “intellectual property” rights associated with it?
Or does it require some rare materials or difficult manufacturing process?
Almost all pharmaceuticals are driven by the cost of drug discovery and studies. You want the cost of drugs to be enough to drive investment into new drugs, but not so much that it becomes impractical for people to afford.